The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors

Michael Lim, Iris C. Gibbs, John R. Adler, David P. Martin, Steven D. Chang

Research output: Contribution to journalArticle

Abstract

Treatment of glomus jugulare tumors with radiosurgery has grown in acceptance since the first reported treatment in 1995, but only a few centers have reported their experiences with limited follow up time. We report our experience with stereotactic radiosurgery in nine patients with ten glomus tumors. All patients were treated either with frame based LINAC or Cyberknife with doses ranging from 1600 cGy to 2500 cGy. Three patients received no previous therapy and one patient received additional external beam radiation for concomitant treatment of carotid body tumors. Patients were then followed for post treatment side effects in addition to change in tumor size by MRI evaluation. The median clinical follow-up time was 26 months (mean 54 months), median radiographic follow-up was 21.5 months (mean 46 months), with a range from 3 to 126 months. The results from our center demonstrated nine of ten tumors to be stable in size by MRI exam, and one tumor which regressed in size. Nine patients had stable neurological symptoms, and one patient experienced transient ipsilateral tongue weakness and hearing loss, both of which subsequently resolved. Our results continue to support radiosurgery as a suitable form of treatment for glomus jugulare tumors as evidenced by results from this four and a half year follow-up.

Original languageEnglish (US)
Pages (from-to)261-265
Number of pages5
JournalTechnology in Cancer Research and Treatment
Volume2
Issue number3
StatePublished - Jun 2003
Externally publishedYes

Fingerprint

Glomus Jugulare Tumor
Radiosurgery
Therapeutics
Carotid Body Tumor
Glomus Tumor
Neoplasms
Hearing Loss
Tongue
Radiation

ASJC Scopus subject areas

  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors. / Lim, Michael; Gibbs, Iris C.; Adler, John R.; Martin, David P.; Chang, Steven D.

In: Technology in Cancer Research and Treatment, Vol. 2, No. 3, 06.2003, p. 261-265.

Research output: Contribution to journalArticle

Lim, Michael ; Gibbs, Iris C. ; Adler, John R. ; Martin, David P. ; Chang, Steven D. / The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors. In: Technology in Cancer Research and Treatment. 2003 ; Vol. 2, No. 3. pp. 261-265.
@article{763da2006aa24c3fa5f974c1d6e30417,
title = "The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors",
abstract = "Treatment of glomus jugulare tumors with radiosurgery has grown in acceptance since the first reported treatment in 1995, but only a few centers have reported their experiences with limited follow up time. We report our experience with stereotactic radiosurgery in nine patients with ten glomus tumors. All patients were treated either with frame based LINAC or Cyberknife with doses ranging from 1600 cGy to 2500 cGy. Three patients received no previous therapy and one patient received additional external beam radiation for concomitant treatment of carotid body tumors. Patients were then followed for post treatment side effects in addition to change in tumor size by MRI evaluation. The median clinical follow-up time was 26 months (mean 54 months), median radiographic follow-up was 21.5 months (mean 46 months), with a range from 3 to 126 months. The results from our center demonstrated nine of ten tumors to be stable in size by MRI exam, and one tumor which regressed in size. Nine patients had stable neurological symptoms, and one patient experienced transient ipsilateral tongue weakness and hearing loss, both of which subsequently resolved. Our results continue to support radiosurgery as a suitable form of treatment for glomus jugulare tumors as evidenced by results from this four and a half year follow-up.",
author = "Michael Lim and Gibbs, {Iris C.} and Adler, {John R.} and Martin, {David P.} and Chang, {Steven D.}",
year = "2003",
month = "6",
language = "English (US)",
volume = "2",
pages = "261--265",
journal = "Technology in Cancer Research and Treatment",
issn = "1533-0346",
publisher = "Adenine Press",
number = "3",

}

TY - JOUR

T1 - The efficacy of linear accelerator stereotactic radiosurgery in treating glomus jugulare tumors

AU - Lim, Michael

AU - Gibbs, Iris C.

AU - Adler, John R.

AU - Martin, David P.

AU - Chang, Steven D.

PY - 2003/6

Y1 - 2003/6

N2 - Treatment of glomus jugulare tumors with radiosurgery has grown in acceptance since the first reported treatment in 1995, but only a few centers have reported their experiences with limited follow up time. We report our experience with stereotactic radiosurgery in nine patients with ten glomus tumors. All patients were treated either with frame based LINAC or Cyberknife with doses ranging from 1600 cGy to 2500 cGy. Three patients received no previous therapy and one patient received additional external beam radiation for concomitant treatment of carotid body tumors. Patients were then followed for post treatment side effects in addition to change in tumor size by MRI evaluation. The median clinical follow-up time was 26 months (mean 54 months), median radiographic follow-up was 21.5 months (mean 46 months), with a range from 3 to 126 months. The results from our center demonstrated nine of ten tumors to be stable in size by MRI exam, and one tumor which regressed in size. Nine patients had stable neurological symptoms, and one patient experienced transient ipsilateral tongue weakness and hearing loss, both of which subsequently resolved. Our results continue to support radiosurgery as a suitable form of treatment for glomus jugulare tumors as evidenced by results from this four and a half year follow-up.

AB - Treatment of glomus jugulare tumors with radiosurgery has grown in acceptance since the first reported treatment in 1995, but only a few centers have reported their experiences with limited follow up time. We report our experience with stereotactic radiosurgery in nine patients with ten glomus tumors. All patients were treated either with frame based LINAC or Cyberknife with doses ranging from 1600 cGy to 2500 cGy. Three patients received no previous therapy and one patient received additional external beam radiation for concomitant treatment of carotid body tumors. Patients were then followed for post treatment side effects in addition to change in tumor size by MRI evaluation. The median clinical follow-up time was 26 months (mean 54 months), median radiographic follow-up was 21.5 months (mean 46 months), with a range from 3 to 126 months. The results from our center demonstrated nine of ten tumors to be stable in size by MRI exam, and one tumor which regressed in size. Nine patients had stable neurological symptoms, and one patient experienced transient ipsilateral tongue weakness and hearing loss, both of which subsequently resolved. Our results continue to support radiosurgery as a suitable form of treatment for glomus jugulare tumors as evidenced by results from this four and a half year follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0141569346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141569346&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 261

EP - 265

JO - Technology in Cancer Research and Treatment

JF - Technology in Cancer Research and Treatment

SN - 1533-0346

IS - 3

ER -